Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M- CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 7, 1997, Pages 1289-1302

  Fruebis, Joachim ^a   Gonzalez, Virginia ^a   Silvestre, Mercedes ^a   Palinski, Wulf ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antioxidants; Arteriosclerosis; Immunocytochemistry; Oxidation; PCR

Indexed keywords

COLONY STIMULATING FACTOR 1; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBUCOL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MORPHOMETRICS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA;

EID: 0030797134     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.7.1289     Document Type: Article

References (12)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3. Palinski W, Witztum JL. Oxidative stress and diabetes mellitus. In: Born GVR, Schwartz CD, eds. New Horizons in Diabetes Mellitus and Coronary Heart Disease. London, UK: Current Science; 1995:111-123.
4. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
5. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA. 1987;84:2995-2998.
6. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a new chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA. 1988;85:2805-2809.
7. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA. 1979;76:333-337.
8. Kodama T, Freeman M, Rohrer L, Zabrecky T, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains alphahelical and collagen-like coiled coils. Nature. 1990;343:531-535.
9. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
10. Ramprasad M, Fischer W, Witztum JL, Sambrano G, Quehenberger O, Steinberg D. The 94-96 kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA. 1995;92:9580-9584.
11. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci USA. 1987;84:7725-7729.
12. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yokida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA. 1987;84:5928-5931.